Greenland Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-205,000
Closed -$3.94M 364
2026
Q1
$3.94M Sell
205,000
-40,000
-16% -$788K 0.5% 45
2025
Q4
$4.64M Buy
245,000
+20,000
+9% +$371K 0.49% 62
2025
Q3
$4.19M Buy
+225,000
New +$4.2M 0.42% 69
2025
Q1
Sell
-40,000
Closed -$693K 419
2024
Q4
$693K Sell
40,000
-375,000
-90% -$6.85M 0.11% 164
2024
Q3
$7.72M Sell
415,000
-140,000
-25% -$2.36M 0.96% 28
2024
Q2
$8.55M Buy
555,000
+206,576
+59% +$2.95M 1.26% 19
2024
Q1
$5.15M Buy
348,424
+78,424
+29% +$1.09M 0.57% 49
2023
Q4
$3.85M Sell
270,000
-175,000
-39% -$2.49M 0.36% 74
2023
Q3
$6.2M Buy
445,000
+70,000
+19% +$896K 0.6% 46
2023
Q2
$4.41M Buy
375,000
+83,000
+28% +$945K 0.48% 62
2023
Q1
$3.36M Buy
+292,000
New +$3.61M 0.37% 96

Other funds holding SBRA

Greenland Capital Management's SBRA Position: Q2 2026 in Review

Greenland Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 205,000 shares — an estimated $3.94M sold.

Greenland Capital Management first reported a position in SBRA in Q1 2023 and held it in 11 quarters. The position peaked at $8.55M in Q2 2024. 465 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Greenland Capital Management reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
  • Greenland Capital Management sold 205,000 Sabra Healthcare REIT shares in Q2 2026, an estimated $3.94M.
  • Greenland Capital Management first reported a position in Sabra Healthcare REIT in Q1 2023 and held it in 11 quarters.
  • Greenland Capital Management's Sabra Healthcare REIT position peaked at $8.55M in Q2 2024.
  • 465 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Greenland Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.